SLC30A7 has anti-oxidant stress effects in high glucose-induced apoptosis via the NFE2L2/HMOX1 signal transduction

Xiuli Zhang1, Tingwen Guan2, Boxuan Yang2

  • 1Department of Nephrology, Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong Province 518000, PR China; Department of Pathophysiology, China Medical University, Shenyang, Liaoning Province 110001, PR China.

Abstract

Insights

Zinc transporter 7 (SLC30A7) protects kidney cells from high glucose-induced apoptosis by reducing oxidative stress. This occurs through the nuclear factor erythroid 2-related factor 2 (NFE2L2)/HMOX1 pathway, offering a potential therapeutic target for diabetic kidney disease.

Area of Science:

  • Cell Biology
  • Renal Physiology
  • Molecular Medicine

Background:

  • Diabetic kidney disease (DKD) pathogenesis involves apoptosis and oxidative stress.
  • Previous work identified SLC30A7 as an inhibitor of apoptosis in mesothelial cells under high glucose (HG).

Purpose of the Study:

  • To investigate the anti-oxidant stress effects of SLC30A7 in renal tubular epithelial cells under HG conditions.

Main Methods:

  • Examined SLC30A7 in HG-induced apoptosis in NRK-52E cells and STZ-induced diabetic mouse kidneys.
  • Analyzed nuclear factor erythroid 2-related factor 2 (NFE2L2) activity using RT-PCR, siRNA, and Western blot.

Main Results:

  • SLC30A7 was upregulated, and NFE2L2 activated in diabetic kidneys and HG-treated cells.
  • SLC30A7 knockdown reduced intracellular zinc and Golgi distribution, increasing HG-induced apoptosis.
  • NFE2L2 knockdown decreased HMOX1 expression and SLC30A7 activity, exacerbating apoptosis.

Conclusions:

  • SLC30A7 exhibits anti-oxidant stress effects against HG-induced apoptosis.
  • These effects are mediated through the NFE2L2/HMOX1 signal transduction pathway.

Related Concept Videos